# Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy

> **NCT07711327** · — · NOT_YET_RECRUITING · sponsor: **Tina Baykaner** · enrollment: 500 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)
- Chronic Lymphocytic Leukemia
- Waldenstrom Macroglobulinemia
- Mantle Cell Lymphoma
- Marginal Zone Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07711327
- **Lead sponsor:** Tina Baykaner
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2031-08
- **Final completion:** 2031-08
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07711327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07711327, "Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07711327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*